HIV Treatment Adherence Dose Determination Trial
ConditionHIV Infections
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity of Connecticut
About this trial
The proposed research will conduct the first dose-determination trial to find the optimal number of behavioral counseling sessions (dose) needed to achieve and sustain optimal HIV treatment adherence. The results of this study will determine how much intervention is needed for whom and at what cost to guide health policy and implementation of behavioral interventions designed to improve durable viral suppression.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Confirmed HIV positive
Confirmed prescribed antiretroviral therapy
Confirmed non-adherent to anti-retroviral therapy
Disqualifiers
Does not have access to a phone
Does not have access to the internet
Trial design
Design model
Parallel
Treatments tested in this trial
Behavioral Self-Regulation Adherence Counseling
BehavioralTelephone-delivered counseling to focus on cognitive-behavioral skills to improve HIV treatment adherence.
Treatment groups
400 Participants
are divided into 2 treatment groupsGroup A: Continuous CounselingActive comparator 1 intervention
Group B: Fixed CounselingActive comparator 1 intervention
Trial outcomes
Primary outcomes
1
Change in Antiretroviral Therapy Adherence from Baseline to 12-Months
Medication adherence defined by percentage of medication doses taken as prescribed
Time frame
12-Month2
Change in HIV Viral Load from Baseline to 12-months
Blood plasma HIV RNA
Time frame
12-monthsSponsors and contacts
Click on the lead sponsor to view all of their trials.
University of Connecticut
Lead sponsor
National Institute of Mental Health (NIMH)
Collaborator
Source ClinicalTrials.gov